Immunological and autoimmune considerations of Autism Spectrum Disorders

Benjamin Gesundheit, Joshua P. Rosenzweig, David Naor, Bernard Lerer, Ditza A. Zachor, Vaclav Procházka, Michal Melamed, Donald A. Kristt, Abraham Steinberg, Cory Shulman, Paul Hwang, Gideon Koren, Asnat Walfisch, Jacob R. Passweg, John A. Snowden, Ryad Tamouza, Marion Leboyer, Dominique Farge-Bancel, Paul Ashwood

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Autism Spectrum Disorders (ASD) are a group of heterogeneous neurodevelopmental conditions presenting in early childhood with a prevalence ranging from 0.7% to 2.64%. Social interaction and communication skills are impaired and children often present with unusual repetitive behavior. The condition persists for life with major implications for the individual, the family and the entire health care system. While the etiology of ASD remains unknown, various clues suggest a possible association with altered immune responses and ASD. Inflammation in the brain and CNS has been reported by several groups with notable microglia activation and increased cytokine production in postmortem brain specimens of young and old individuals with ASD. Moreover several laboratories have isolated distinctive brain and CNS reactive antibodies from individuals with ASD. Large population based epidemiological studies have established a correlation between ASD and a family history of autoimmune diseases, associations with MHC complex haplotypes, and abnormal levels of various inflammatory cytokines and immunological markers in the blood. In addition, there is evidence that antibodies that are only present in some mothers of children with ASD bind to fetal brain proteins and may be a marker or risk factor for ASD. Studies involving the injection of these ASD specific maternal serum antibodies into pregnant mice during gestation, or gestational exposure of Rhesus monkeys to IgG subclass of these antibodies, have consistently elicited behavioral changes in offspring that have relevance to ASD. We will summarize the various types of studies associating ASD with the immune system, critically evaluate the quality of these studies, and attempt to integrate them in a way that clarifies the areas of immune and autoimmune phenomena in ASD research that will be important indicators for future research.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalJournal of Autoimmunity
Volume44
DOIs
StatePublished - Aug 2013

Fingerprint

Antibodies
Autism Spectrum Disorder
Brain
Mothers
Fetal Proteins
Cytokines
Family Health
Microglia
Encephalitis
Interpersonal Relations
Macaca mulatta
Haplotypes
Autoimmune Diseases
Epidemiologic Studies
Immune System
Immunoglobulin G
Communication
Delivery of Health Care
Pregnancy
Injections

Keywords

  • Autism Spectrum Disorders
  • Autoantibodies
  • Brain inflammation
  • Cytokines
  • HLA association
  • Microglia

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Gesundheit, B., Rosenzweig, J. P., Naor, D., Lerer, B., Zachor, D. A., Procházka, V., ... Ashwood, P. (2013). Immunological and autoimmune considerations of Autism Spectrum Disorders. Journal of Autoimmunity, 44, 1-7. https://doi.org/10.1016/j.jaut.2013.05.005

Immunological and autoimmune considerations of Autism Spectrum Disorders. / Gesundheit, Benjamin; Rosenzweig, Joshua P.; Naor, David; Lerer, Bernard; Zachor, Ditza A.; Procházka, Vaclav; Melamed, Michal; Kristt, Donald A.; Steinberg, Abraham; Shulman, Cory; Hwang, Paul; Koren, Gideon; Walfisch, Asnat; Passweg, Jacob R.; Snowden, John A.; Tamouza, Ryad; Leboyer, Marion; Farge-Bancel, Dominique; Ashwood, Paul.

In: Journal of Autoimmunity, Vol. 44, 08.2013, p. 1-7.

Research output: Contribution to journalArticle

Gesundheit, B, Rosenzweig, JP, Naor, D, Lerer, B, Zachor, DA, Procházka, V, Melamed, M, Kristt, DA, Steinberg, A, Shulman, C, Hwang, P, Koren, G, Walfisch, A, Passweg, JR, Snowden, JA, Tamouza, R, Leboyer, M, Farge-Bancel, D & Ashwood, P 2013, 'Immunological and autoimmune considerations of Autism Spectrum Disorders', Journal of Autoimmunity, vol. 44, pp. 1-7. https://doi.org/10.1016/j.jaut.2013.05.005
Gesundheit B, Rosenzweig JP, Naor D, Lerer B, Zachor DA, Procházka V et al. Immunological and autoimmune considerations of Autism Spectrum Disorders. Journal of Autoimmunity. 2013 Aug;44:1-7. https://doi.org/10.1016/j.jaut.2013.05.005
Gesundheit, Benjamin ; Rosenzweig, Joshua P. ; Naor, David ; Lerer, Bernard ; Zachor, Ditza A. ; Procházka, Vaclav ; Melamed, Michal ; Kristt, Donald A. ; Steinberg, Abraham ; Shulman, Cory ; Hwang, Paul ; Koren, Gideon ; Walfisch, Asnat ; Passweg, Jacob R. ; Snowden, John A. ; Tamouza, Ryad ; Leboyer, Marion ; Farge-Bancel, Dominique ; Ashwood, Paul. / Immunological and autoimmune considerations of Autism Spectrum Disorders. In: Journal of Autoimmunity. 2013 ; Vol. 44. pp. 1-7.
@article{449316d4e83b45cbb231709efe095415,
title = "Immunological and autoimmune considerations of Autism Spectrum Disorders",
abstract = "Autism Spectrum Disorders (ASD) are a group of heterogeneous neurodevelopmental conditions presenting in early childhood with a prevalence ranging from 0.7{\%} to 2.64{\%}. Social interaction and communication skills are impaired and children often present with unusual repetitive behavior. The condition persists for life with major implications for the individual, the family and the entire health care system. While the etiology of ASD remains unknown, various clues suggest a possible association with altered immune responses and ASD. Inflammation in the brain and CNS has been reported by several groups with notable microglia activation and increased cytokine production in postmortem brain specimens of young and old individuals with ASD. Moreover several laboratories have isolated distinctive brain and CNS reactive antibodies from individuals with ASD. Large population based epidemiological studies have established a correlation between ASD and a family history of autoimmune diseases, associations with MHC complex haplotypes, and abnormal levels of various inflammatory cytokines and immunological markers in the blood. In addition, there is evidence that antibodies that are only present in some mothers of children with ASD bind to fetal brain proteins and may be a marker or risk factor for ASD. Studies involving the injection of these ASD specific maternal serum antibodies into pregnant mice during gestation, or gestational exposure of Rhesus monkeys to IgG subclass of these antibodies, have consistently elicited behavioral changes in offspring that have relevance to ASD. We will summarize the various types of studies associating ASD with the immune system, critically evaluate the quality of these studies, and attempt to integrate them in a way that clarifies the areas of immune and autoimmune phenomena in ASD research that will be important indicators for future research.",
keywords = "Autism Spectrum Disorders, Autoantibodies, Brain inflammation, Cytokines, HLA association, Microglia",
author = "Benjamin Gesundheit and Rosenzweig, {Joshua P.} and David Naor and Bernard Lerer and Zachor, {Ditza A.} and Vaclav Proch{\'a}zka and Michal Melamed and Kristt, {Donald A.} and Abraham Steinberg and Cory Shulman and Paul Hwang and Gideon Koren and Asnat Walfisch and Passweg, {Jacob R.} and Snowden, {John A.} and Ryad Tamouza and Marion Leboyer and Dominique Farge-Bancel and Paul Ashwood",
year = "2013",
month = "8",
doi = "10.1016/j.jaut.2013.05.005",
language = "English (US)",
volume = "44",
pages = "1--7",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Immunological and autoimmune considerations of Autism Spectrum Disorders

AU - Gesundheit, Benjamin

AU - Rosenzweig, Joshua P.

AU - Naor, David

AU - Lerer, Bernard

AU - Zachor, Ditza A.

AU - Procházka, Vaclav

AU - Melamed, Michal

AU - Kristt, Donald A.

AU - Steinberg, Abraham

AU - Shulman, Cory

AU - Hwang, Paul

AU - Koren, Gideon

AU - Walfisch, Asnat

AU - Passweg, Jacob R.

AU - Snowden, John A.

AU - Tamouza, Ryad

AU - Leboyer, Marion

AU - Farge-Bancel, Dominique

AU - Ashwood, Paul

PY - 2013/8

Y1 - 2013/8

N2 - Autism Spectrum Disorders (ASD) are a group of heterogeneous neurodevelopmental conditions presenting in early childhood with a prevalence ranging from 0.7% to 2.64%. Social interaction and communication skills are impaired and children often present with unusual repetitive behavior. The condition persists for life with major implications for the individual, the family and the entire health care system. While the etiology of ASD remains unknown, various clues suggest a possible association with altered immune responses and ASD. Inflammation in the brain and CNS has been reported by several groups with notable microglia activation and increased cytokine production in postmortem brain specimens of young and old individuals with ASD. Moreover several laboratories have isolated distinctive brain and CNS reactive antibodies from individuals with ASD. Large population based epidemiological studies have established a correlation between ASD and a family history of autoimmune diseases, associations with MHC complex haplotypes, and abnormal levels of various inflammatory cytokines and immunological markers in the blood. In addition, there is evidence that antibodies that are only present in some mothers of children with ASD bind to fetal brain proteins and may be a marker or risk factor for ASD. Studies involving the injection of these ASD specific maternal serum antibodies into pregnant mice during gestation, or gestational exposure of Rhesus monkeys to IgG subclass of these antibodies, have consistently elicited behavioral changes in offspring that have relevance to ASD. We will summarize the various types of studies associating ASD with the immune system, critically evaluate the quality of these studies, and attempt to integrate them in a way that clarifies the areas of immune and autoimmune phenomena in ASD research that will be important indicators for future research.

AB - Autism Spectrum Disorders (ASD) are a group of heterogeneous neurodevelopmental conditions presenting in early childhood with a prevalence ranging from 0.7% to 2.64%. Social interaction and communication skills are impaired and children often present with unusual repetitive behavior. The condition persists for life with major implications for the individual, the family and the entire health care system. While the etiology of ASD remains unknown, various clues suggest a possible association with altered immune responses and ASD. Inflammation in the brain and CNS has been reported by several groups with notable microglia activation and increased cytokine production in postmortem brain specimens of young and old individuals with ASD. Moreover several laboratories have isolated distinctive brain and CNS reactive antibodies from individuals with ASD. Large population based epidemiological studies have established a correlation between ASD and a family history of autoimmune diseases, associations with MHC complex haplotypes, and abnormal levels of various inflammatory cytokines and immunological markers in the blood. In addition, there is evidence that antibodies that are only present in some mothers of children with ASD bind to fetal brain proteins and may be a marker or risk factor for ASD. Studies involving the injection of these ASD specific maternal serum antibodies into pregnant mice during gestation, or gestational exposure of Rhesus monkeys to IgG subclass of these antibodies, have consistently elicited behavioral changes in offspring that have relevance to ASD. We will summarize the various types of studies associating ASD with the immune system, critically evaluate the quality of these studies, and attempt to integrate them in a way that clarifies the areas of immune and autoimmune phenomena in ASD research that will be important indicators for future research.

KW - Autism Spectrum Disorders

KW - Autoantibodies

KW - Brain inflammation

KW - Cytokines

KW - HLA association

KW - Microglia

UR - http://www.scopus.com/inward/record.url?scp=84881375626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881375626&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2013.05.005

DO - 10.1016/j.jaut.2013.05.005

M3 - Article

C2 - 23867105

AN - SCOPUS:84881375626

VL - 44

SP - 1

EP - 7

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

ER -